Published on in CHOP News
The Mitochondria and Cancer Connections (MC²) Research Program will study how cancer cells find the energy to grow and ways to prevent their return.
Published on in CHOP News
Outcome measurements revealed information about muscle weakness and differences between pediatric and adult patients.
Published on in Children's View
Researchers at CHOP discovered the genetic cause of two brothers’ early deaths. Now, their family seeks to further propel mitochondrial disease research with a $2 million gift.
Published on in CHOP News
New findings set stage for future targeted therapies for patients with 22q11.2 deletion syndrome, who are 25 times more likely to develop schizophrenia.
Published on in CHOP News
Study is first to demonstrate how one specific combinational therapy may provide measurable benefits to patients with mitochondrial respiratory chain disorders, which currently lack FDA-approved therapies.
Published on in CHOP News
Early research shows how mild defects in the “batteries” of cells in brain tissue can lead to behaviors similar to those of autism.
Published on in CHOP News
Improved and standardized variant curation guidelines will improve diagnostic accuracy for patients with mitochondrial disease evaluation.
Published on in CHOP News
CHOP’S Mitochondrial Medicine team helped bring this book for researchers and clinicians to life.
Published on in CHOP News
CHOP Researchers Discover New, Aggressive Form of Mitochondrial Disease.
Published on in CHOP News
The international prize is given each year to a scientist who has demonstrated outstanding achievement in research in the broad field of mitochondrial biology.